Digital neuropsychological measures by defense automated neurocognitive assessment: reference values and clinical correlates

Huitong Ding, Minzae Kim, Edward Searls, Preeti Sunderaraman, Ileana De Anda‐Duran, Spencer Low, Zachary Popp, Phillip H Hwang, Zexu Li, Kriti Goyal, Lindsay Hathaway, Jose Monteverde, Salman Rahman, Akwaugo Igwe, Vijaya B. Kolachalama, Rhoda Au, Honghuang LinFrontiers in Neurology 2024 · DOI

Abstract

This study established and validated reference values for digital neuropsychological measures of the Defense Automated Neurocognitive Assessment (DANA) in cognitively intact white participants. By providing age- and sex-stratified norms, the research aims to improve the utility of mobile cognitive testing in clinical practice and future research for detecting early cognitive decline.

Introduction

As the global prevalence of Alzheimer’s disease increases, there is an urgent need for "digital biomarkers"—objective, rapid, and cost-effective methods to monitor brain health. Traditional paper-and-pencil neuropsychological tests, while effective, are often time-consuming and require specialized administration. Smartphone-based applications like DANA offer a scalable solution; however, their clinical utility has been limited by a lack of normative data. Without established reference values, raw digital scores remain difficult to interpret. This study addresses this gap by establishing comprehensive reference values and exploring the clinical correlates of digital cognitive performance.

Methods

The study focused on three core tasks within the DANA suite: Code Substitution (cognitive flexibility), Go-No-Go (inhibitory control), and Simple Reaction Time (processing speed). Performance was quantified using reference values at the 2.5th, 25th, 50th (median), 75th, and 97.5th percentiles. To identify clinical correlates, researchers employed a backward elimination linear regression strategy, evaluating 19 risk factors—including BMI, smoking status, blood pressure, and cholesterol—to determine independent predictors of task performance.

Study Populations

The research utilized two distinct cohorts of cognitively intact white participants to establish and validate the norms. The primary reference cohort consisted of 932 participants from the Framingham Heart Study (FHS), while a smaller validation cohort of 57 participants was drawn from the Boston University Alzheimer’s Disease Research Center (BU ADRC).

Demographic characteristics of the FHS and BU ADRC cohorts.

Results and Key Insights

The Aging Clock and Sex Differences

Performance across all DANA tasks showed a predictable decline with age, reinforcing processing speed as a sensitive indicator of brain aging. Interestingly, the study identified a "cross-over" in performance based on sex: women significantly outperformed men in the Code Substitution task ($p=0.03$), whereas men generally exhibited faster reaction times in the Go-No-Go and Simple Reaction Time tasks.

Performance metrics across age groups and sex for DANA tasks.

Clinical and Metabolic Correlates

Digital measures proved sensitive to metabolic health. Slower response times in Code Substitution were independently associated with higher total cholesterol and diabetes. Conversely, Go-No-Go performance was linked to blood glucose levels and systolic blood pressure. Additionally, higher educational attainment (college degree or higher) was consistently associated with faster reaction times, suggesting the influence of cognitive reserve on digital task performance.

Validation of Norms

Heatmap analysis confirmed that the majority of the BU ADRC validation cohort fell within the "normal" range (2.5th to 97.5th percentile) established by the FHS data, indicating that the reference values are robust and generalizable across different clinical settings.

Discussion and Limitations

While this study provides a vital benchmark for digital neurocognitive assessment, several limitations remain. The sample was exclusively composed of white participants, necessitating future research to establish norms for diverse ethnic populations. Furthermore, the requirement for smartphone ownership and internet access may introduce selection bias toward individuals of higher socioeconomic status. Finally, while DANA measures processing speed and executive function, it does not currently include episodic memory tasks, which are critical for early Alzheimer's detection. Future iterations of digital batteries should aim for finer age stratification and broader cognitive domain coverage.

Summary updated

Abstract

This study established and validated reference values for digital neuropsychological measures of DANA in cognitively intact white participants, potentially improving their use in future clinical studies and practice.
BibTeX
@inproceedings{ding2024digital,
  author = {Huitong Ding and Minzae Kim and Edward Searls and Preeti Sunderaraman and Ileana De Anda‐Duran and Spencer Low and Zachary Popp and Phillip H Hwang and Zexu Li and Kriti Goyal and Lindsay Hathaway and Jose Monteverde and Salman Rahman and Akwaugo Igwe and Vijaya B. Kolachalama and Rhoda Au and Honghuang Lin},
  title = {{Digital neuropsychological measures by defense automated neurocognitive assessment: reference values and clinical correlates}},
  booktitle = {Frontiers in Neurology},
  year = {2024},
  doi = {10.3389/fneur.2024.1340710},
}
Figure